AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.370

-0.030-7.50%

Volume:3.81M

Turnover:1.46M

Market Cap:154.74M

PE:-47.93

High:0.410

Open:0.385

Low:0.370

Close:0.400

52wk High:0.525

52wk Low:0.082

Shares:418.22M

Float Shares:347.84M

Volume Ratio:4.17

T/O Rate:1.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.008

EPS(LYR):-0.024

ROE:-14.47%

ROA:-7.24%

PB:7.20

PE(LYR):-15.45

Loading ...

Overview Company News Filings

Company Profile

Company Name:

STARPHARMA HOLDINGS LTD

Exchange:

ASX

Establishment Date:

1997

Employees:

40

Office Location:

4-6 Southampton Crescent,Abbotsford,Victoria,Australia

Website:

http://starpharma.com

Zip Code:

3067

Phone:

Fax:

61 3 9510 5955

Introduction:

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SPL.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","market":"AU","secType":"STK","nameCN":"STARPHARMA HOLDINGS LTD","latestPrice":0.37,"timestamp":1772601120000,"preClose":0.4,"halted":0,"volume":3805269,"delay":0,"changeRate":-0.07500000000000007,"nameEN":"STARPHARMA HOLDINGS LTD","floatShares":347835291,"shares":418224781,"eps":-0.007719,"marketStatus":"Not Yet Opened","change":-0.03,"latestTime":"03-04 16:12:00 AEDT","open":0.385,"high":0.41,"low":0.37,"amount":1464814,"amplitude":0.1,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.007719,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772665200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.4,"openAndCloseTimeList":[[1772578800000,1772600400000]],"volumeRatio":4.1729894963616285,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","floatShares":347835291,"roa":"-7.24%","roe":"-14.47%","lyrEps":-0.023946,"volumeRatio":4.1729894963616285,"shares":418224781,"dividePrice":0,"high":0.41,"amplitude":0.1,"preClose":0.4,"low":0.37,"week52Low":0.082,"pbRate":"7.20","psRate":"10.61","week52High":0.525,"institutionHeld":0,"latestPrice":0.37,"eps":-0.007719,"divideRate":0,"volume":3805269,"delay":0,"ttmEps":-0.007719,"open":0.385,"prevYearClose":0.36,"prevWeekClose":0.46,"prevMonthClose":0.46,"prevQuarterClose":0.36,"fiveDayClose":0.485,"twentyDayClose":0.41,"sixtyDayClose":0.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPL.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":4493458,"yearFounded":1997,"employeeNum":40,"address":"4-6 Southampton Crescent,Abbotsford,Victoria,Australia","zipCode":"3067","officePhone":"61 3 8532 2700","officeFax":"61 3 9510 5955"},"stockCompanyDetail":{"websiteUrl":"http://starpharma.com","stockEarnings":[{"period":"1week","weight":-0.1304},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.0959},{"period":"6month","weight":2.0769},{"period":"1year","weight":2.4783},{"period":"ytd","weight":0.1111}],"compareEarnings":[{"period":"1week","weight":-0.0065},{"period":"1month","weight":0.0134},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0797},{"period":"1year","weight":0.1591},{"period":"ytd","weight":0.0155}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.018875},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.025324},{"month":3,"riseRate":0.36,"avgChangeRate":0.004587},{"month":4,"riseRate":0.32,"avgChangeRate":-0.016831},{"month":5,"riseRate":0.36,"avgChangeRate":-0.041001},{"month":6,"riseRate":0.56,"avgChangeRate":0.039433},{"month":7,"riseRate":0.44,"avgChangeRate":0.004085},{"month":8,"riseRate":0.68,"avgChangeRate":0.099337},{"month":9,"riseRate":0.5,"avgChangeRate":0.017446},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.016585},{"month":11,"riseRate":0.5,"avgChangeRate":0.028409},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.005804}],"exchange":"ASX","name":"STARPHARMA HOLDINGS LTD","nameEN":"STARPHARMA HOLDINGS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":null}}